The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 18, 2017
Filed:
Dec. 03, 2013
Applicant:
Bayer Pharma Aktiengesellschaft, Berlin, DE;
Inventors:
Olaf Peters, Tabarz, DE;
Nico Bräuer, Falkensee, DE;
Thorsten Blume, Wuppertal, DE;
Antonius Ter Laak, Berlin, DE;
Ludwig Zorn, Berlin, DE;
Jens Nagel, Daxweiler, DE;
Stefan Kaulfuss, Berlin, DE;
Gernot Langer, Falkensee, DE;
Joachim Kuhnke, Potsdam, DE;
Assignee:
BAYER PHARMA AKTIENGESELLSCHAFT, Berlin, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/04 (2006.01); C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 471/04 (2006.01); A61K 31/437 (2006.01); A61K 31/4184 (2006.01); A61P 5/00 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/4184 (2013.01); A61K 31/437 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01);
Abstract
The present invention relates to novel benzimidazole derivatives of the general formula processes for their preparation and their use for the production of pharmaceutical compositions for the treatment of diseases and indications that are connected with the receptor EP4.